GE HealthCare Technologies (GEHC) Projected to Post Quarterly Earnings on Wednesday

GE HealthCare Technologies (NASDAQ:GEHC) is projected to issue its Q3 2026 results before the market opens on Wednesday, October 28th. Analysts expect GE HealthCare Technologies to announce earnings of $1.20 per share and revenue of $5.35 billion for the quarter. Investors are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Wednesday, October 28, 2026 at 8:30 AM ET.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.09. The business had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.06 earnings per share. On average, analysts expect GE HealthCare Technologies to post $4.93 EPS for the current fiscal year and $5.41 EPS for the next fiscal year.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $70.23 on Wednesday. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.26 and a quick ratio of 0.97. GE HealthCare Technologies has a 1 year low of $58.75 and a 1 year high of $89.77. The firm has a market capitalization of $31.72 billion, a PE ratio of 16.11, a P/E/G ratio of 1.84 and a beta of 0.73. The business’s 50 day moving average price is $68.42 and its 200-day moving average price is $66.76.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be issued a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 23rd. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s payout ratio is 3.21%.

Analysts Set New Price Targets

Several equities research analysts have issued reports on GEHC shares. Oppenheimer reaffirmed an “outperform” rating on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. BMO Capital Markets assumed coverage on shares of GE HealthCare Technologies in a research report on Wednesday, July 8th. They issued a “market perform” rating and a $70.00 target price for the company. Evercore restated an “outperform” rating and set a $84.00 target price on shares of GE HealthCare Technologies in a report on Thursday, July 30th. Hovde Group began coverage on GE HealthCare Technologies in a report on Friday, July 17th. They issued a “market perform” rating and a $14.00 price target for the company. Finally, Piper Sandler reiterated a “buy” rating on shares of GE HealthCare Technologies in a research report on Wednesday, July 29th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $78.35.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company’s portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.